Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes

Journal of Experimental Medicine

Volumn 176, Issue 6, 1992, Pages 1739-1744

  Miller, Michael D ^a   Gould Fogerite, Susan ^b   Shen, Ling ^a   Woods, Robert M ^c   Koenig, Scott ^c   Mannino, Raphael J ^b   Letvin, Norman L ^a  

^a NEW ENGLAND PRIMATE RESEARCH CENTER   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c SMedimmune Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAG PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SYNTHETIC PEPTIDE; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG DESIGN; ENCAPSULATION; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEOLIPOSOME; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

AMINO ACID SEQUENCE; ANIMAL; ANTIGENS, CD8; CELL LINE; GENE PRODUCTS, GAG; GENES, MHC CLASS I; LIPOSOMES; MACACA MULATTA; MEMBRANE FUSION; MOLECULAR SEQUENCE DATA; PROTEOLIPIDS; SIV; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0026486222     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.176.6.1739     Document Type: Article

References (26)

1. Murphy-Corb, M., L.N. Martin, and B. Davison-Fairburn. 1989. A formalin-inactivated whole SIV vaccine confers protection in macaques. Science (Wish. DC). 246:1293.
2. Desrosiers, R.C., M.S. Wyand, T. Kodama, D. Ringler, L.O. Arthur, P.K. Sehgal, N.L. Letvin, N.W. King, and M.D. Daniel. 1989. Vaccine protection against SIV infection. Proc. Natl. Acad. Sci. USA. 86:6353.
3. Osterhaus, A., P. DeVries, and J. Heeney. 1992. AIDS vaccine developments. Nature (Lond.). 355:684.
4. Hu, S.-L., K. Abrams, G.N. Barber, P. Moran, J.M. Zarling, A.J. Langlois, L. Kuller, W.R. Morton, and R.E. Benveniste. 1992. Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gpl60. Science (Wish. DC). 255:456.
5. + cytotoxic T lymphocytes. Science (Wash. DC). 252:440.
6. Redfield, R.R., D.C. Wright, W.D. James, T.S. Jones, C. Brown, and D.S. Burke. 1987. Disseminated vaccinia in a military recruit with HIV disease. N. Engl. J. Med. 316:673.
7. Zagury, D. 1991. Anti-HIV cellular immunotherapy in AIDS. Lancet. 338:694.
8. Morrison, L.A., A.E. Lukacher, V.L. Braciale, D.P. Fan, and T.J. Braciale. 1986. Differences in antigen presentation to MHC class I and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. J. Exp Med. 163:903.
9. Gething, M.J., U. Koszinowski, and M. Waterfield. 1978. Fusion of Sendai virus with the target cell membrane is required for T cell cytotoxicity. Nature (Lond.). 274:689.
10. Moore, M.W., F.R. Carbone, and M.J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen presentation. Cell. 54:777.
11. Yewdell, J., J.R. Bennink, and Y. Hosaka. 1988. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science (Wish. DC). 239:637.
12. Mannino, R.J., and S. Gould-Forgerite. 1988. Liposome mediated gene transfer. BioTechniques. 6:682.
13. Gould-Fogerite, S., J.E. Mazurkiewicz, J.M. Lehman, K. Raska, Jr., and R.J. Mannino. 1989. Chimerosome mediated gene transfer in vitro and in vivo. Gene (Amst.). 84:429.
14. Miller, M.D., H. Yamamoto, A.L. Hughes, D.I. Watkins, and N.L. Letvin. 1991. Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys. J. Immunol. 147:320.
15. Deres, K., H. Schild, K.-H. Wiesmuller, G. Jung, and H.-G. Rammensee. 1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature (Lond.). 342:561.
16. + cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature (Lond.). 344:873.
17. Schulz, M., R.M. Zinkernagel, and H. Hengartner. 1991. Peptide-induced antiviral protection by cytotoxic T cells. Proc. Natl. Acad. Sci. USA. 88:991.
18. Collins, D.S., F. Findlay, and C.V. Harding. 1992. Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses.J. Immunol. 148:3336.
19. Nair, S., F. Zhou, R. Reddy, L. Huang, and B.T. Rouse. 1992. Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. J. Exp Med. 175:609.
20. Carbone, F.R., and M.J. Bevan. 1989. Induction of ovalbumin-specific CTL by in vivo peptide immunization. J. Exp Med. 169:603.
21. Golding, H., G.M. Shearer, K. Hillman, P. Lucas, J. Manis-chewitz, R.A. Zajac, M. Clerici, R.E. Gress, R.N. Boswell, and B. Golding. 1989. Common epitope in HIV l-gp41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV-infected individuals. J. Clin. Invest. 83:1430.
22. Takeda, A., C.U. Tuazon, and F.A. Ennis. 1988. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science (Wash. DC). 242:580.
23. Nixon, D.F., and A.J. McMichael. 1991. Cytotoxic T cell recognition of HIV proteins and peptides. AIDS (Phila.). 5:1049.
24. Goodman-Snitkoff, G., M. Good, J. Berzofsky, and R.J. Mannino. 1991. Role of intrastructural/intermolecular help in immunization with peptide-phospholipid complexes.J. Immunol. 147:410.
25. Shimizu, Y., and R. DeMars. 1989. Production of human cells expressing individual transferred HLA-A, -B, -C genes using an HLA-A, -B, -C null human cell line.J. Immunol. 142:3320.
26. Miller, M.D., C.I. Lord, V. Stallard, G. Mazzara, and N.L. Letvin. 1990. Gag-specific cytotoxic T lymphocytes in rhesus monkqrs infected with the simian immunodeficiency virus of macaques. J. Immunol. 144:122.